Effect of a Low Glycemic Index/Slow Digesting (LGI/SD) Carbohydrate Product on Maternal Glycemia and Neonatal Body Composition in Obese Pregnant Women: The NIGOHealth Randomized Clinical Trial
Nutrients · 2025
DOI: 10.3390/nu17111942 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, 2025. Verfasst von Mercedes G Bermúdez und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, School of Medicine, University of Granada, Avda. de la Investigación 11, 18016 Granada, Spain. Hauptthemen laut MEDLINE: Blood Glucose, Glycemic Index, Obesity, Body Composition. Die Arbeit nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Commission's 7th Framework Program EarlyNutrition project (FP7-289346-EarlyNutrition), Abbott Nutrition, DynaHEALTH EU Project.
Abstract (Originalsprache)
Background/Objectives: Obesity during pregnancy is strongly related to increased insulin resistance, and subsequent development of metabolic syndrome-like disorders, such as glucose intolerance, pre-eclampsia, as well as preterm birth, and cesarean delivery. Nutrition can influence the evolution of glycemic response and may help improve adverse pregnancy outcomes and long-term complications. The main objective of the Nutritional Intervention during Gestation and Offspring Health (NIGOHealth) randomized clinical trial (ClinicalTrials.gov Identifier: NCT02285764) was to investigate the potential effects of a low glycemic index/slow digesting (LGI/SD) carbohydrate product on maternal glycemia (glucose AUC at 27+0–28+6 weeks; maternal fasting blood glucose (MFBG) at 34+0–36+0 weeks), and neonatal body composition.
Methods
Obese pregnant women were randomized: 230 in the intervention group (IG), who consumed two servings of an LGI/SD study product daily from 15 weeks of pregnancy until delivery, and 102 participants in the Standard of Care (SOC) group.
Results
When analyzing baseline characteristics, significant differences were found in glucose metabolic parameters with higher values for IG than for the SOC group, compromising the group’s comparability. Despite this, a statistical analysis was conducted (intention-to-treat analysis/evaluable cohort): no differences were detected regarding maternal blood glucose AUC at 27+0–28+6 weeks, nor for MFBG at 34+0–36+0 weeks. Nonetheless, HbA1c (%) at 34+0–36+0 weeks was significantly lower in the IG vs. the SOC group (5.26 ± 0.03, 5.31 ± 0.04, p = 0.007) after adjusting for baseline conditions.
Conclusion
This result might suggest a potential effect of the intervention on Evaluable participants. However, it should be taken with caution, due to the limitations of the study. More RCTs should be carried out to explore the effects of LGI/SD products on glycemic response in obese pregnant women.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, School of Medicine, University of Granada, Avda. de la Investigación 11, 18016 Granada, Spain.
- Instituto de Investigación Biosanitaria ibs.GRANADA, Health Sciences Technological Park, 18012 Granada, Spain.
- Department of Obstetrics & Gynaecology, Hospital Universitario Virgen de las Nieves, Avda. Fuerzas Armadas s/n, 18014 Granada, Spain.
- Gynaecology and Obstetrics Unit, Hospital Universitario Clínico San Cecilio, Avda. Conocimiento, s/n, 18016 Granada, Spain.
- Department of Obstetrics and Gynecology, Faculty of Medicine, University of Granada, Avda. Investigación 11, 18016 Granada, Spain.
- Department of Paediatrics, LMU-Ludwig Maximilians Universitaet Munich, Dr. von Hauner Children's LMU University Hospital, 80337 Munich, Germany.
ORCID-Profile: Mercedes G Bermúdez, Alberto Puertas-Prieto, Geraldine E Baggs, Ricardo Rueda, Cristina Campoy
Förderung
- European Commission's 7th Framework Program EarlyNutrition project (FP7-289346-EarlyNutrition)
- Abbott Nutrition
- DynaHEALTH EU Project
- PREcisE JPI-ERA-HDHL-Epigenetics
- The European Commission’s 7th Framework Program EarlyNutrition Project (FP7-289346-EarlyNutrition)
- Horizon 2020 DynaHEALTH EU Project
- Else Kröner-Fresenius-Foundation
Zitieren
APA
G Bermúdez, M., García-Ricobaraza, M., García-Santos, J. A., Segura, M. T., Puertas-Prieto, A., Gallo-Vallejo, J. L., Padilla-Vinuesa, C., Koletzko, B., Baggs, G. E., Oliveros, E., Rueda, R., & Campoy, C. (2025). Effect of a Low Glycemic Index/Slow Digesting (LGI/SD) Carbohydrate Product on Maternal Glycemia and Neonatal Body Composition in Obese Pregnant Women: The NIGOHealth Randomized Clinical Trial. Nutrients. https://doi.org/10.3390/nu17111942
Vancouver
G Bermúdez M, García-Ricobaraza M, García-Santos JA, Segura MT, Puertas-Prieto A, Gallo-Vallejo JL, et al. Effect of a Low Glycemic Index/Slow Digesting (LGI/SD) Carbohydrate Product on Maternal Glycemia and Neonatal Body Composition in Obese Pregnant Women: The NIGOHealth Randomized Clinical Trial. Nutrients. 2025. doi:10.3390/nu17111942
BibTeX
@article{GBermdez2025,
author = {G Bermúdez, Mercedes and García-Ricobaraza, María and García-Santos, José Antonio and Segura, M Teresa and Puertas-Prieto, Alberto and Gallo-Vallejo, José Luis and Padilla-Vinuesa, Carmen and Koletzko, Berthold and Baggs, Geraldine E and Oliveros, Elena and Rueda, Ricardo and Campoy, Cristina},
title = {Effect of a Low Glycemic Index/Slow Digesting (LGI/SD) Carbohydrate Product on Maternal Glycemia and Neonatal Body Composition in Obese Pregnant Women: The NIGOHealth Randomized Clinical Trial},
journal = {Nutrients},
year = {2025},
doi = {10.3390/nu17111942}
}
EUVIMED